MCK · McKesson Corporation
$840.90
+4.64% last session
End-of-day data · updated 2026-07-28
Market cap
$100B
Enterprise value
$108B
Trailing P/E
22.2
Forward P/E
16.9
Dividend yield
0.0%
Beta
0.32
Avg volume
1M
Employees
42K
2D change
—
5D change
3.10%
10D change
1.03%
30D change
11.34%
60D change
14.62%
MTD change
10.68%
YTD change
3.83%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — MCK
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-24
Latest call per bank · past 12 months
Citigroup
Buy$1,000
+18.9% vs priceBarclays
Overweight$925
+10.0% vs priceWells Fargo
Equal-Weight$812
-3.4% vs priceUBS
Buy$1,050
+24.9% vs priceJP Morgan
Overweight$1,015
+20.7% vs priceBank of America
Buy$1,000
+18.9% vs priceMorgan Stanley
Overweight$916
+8.9% vs priceJefferies
Buy$900
+7.0% vs priceDeutsche Bank
Buy$856
+1.8% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-24 | Citigroup | Maintains | Buy | $945 → $1,000 |
| 2026-07-21 | TD Cowen | Maintains | Buy | $1,012 → $989 |
| 2026-06-10 | Barclays | Maintains | Overweight | $1,050 → $925 |
| 2026-05-14 | Citigroup | Maintains | Buy | $975 → $945 |
| 2026-05-12 | Wells Fargo | Maintains | Equal-Weight | $925 → $812 |
| 2026-05-08 | UBS | Maintains | Buy | $1,000 → $1,050 |
| 2026-05-08 | JP Morgan | Maintains | Overweight | $1,107 → $1,015 |
| 2026-05-08 | Evercore ISI Group | Maintains | Outperform | $950 → $850 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 71 — overbought territory; the recent run-up may be due for a pause.
- Price vs 50-day MA: Trading 13.8% above the 50-day MA ($781.76).
- Price vs 200-day MA: Trading 6.8% above the 200-day MA ($832.62).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is positive (+5.87) — short-term momentum is improving.
- 52-week range: Price sits between the 52-week low ($656.34) and high ($994.59).
MCK Price Chart
Loading chart for MCK…
Fundamentals
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
More in Medical Distribution
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.